NDRAW
ENDRA Life Sciences Inc. Warrants [NDRAW] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NDRAW Stock Summary
In the News
NDRAW Financial details
Company Rating
-
Market Cap
0
Income
-11.94M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.04
Forward P/E
-
PEG
-0.34
P/S
-
P/B
0.04
P/C
-
P/FCF
-
Quick Ratio
6.13
Current Ratio
7.83
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.86
EPS next Y
-
EPS next Q
-
EPS this Y
-3.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-15.91%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-8.7%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-88%
ROE
-126%
ROC
-0.99%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-1%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.01-0.03
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
4.2321
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- CEO None
- Headquarters US
- IPO Date 2017-06-28
